New Results
Genomic patterns of malignant peripheral nerve sheath tumour (MPNST) evolution correlate with clinical outcome and are detectable in cell-free DNA
View ORCID ProfileI Cortes-Ciriano, CD Steele, K Piculell, A Al-Ibraheemi, V Eulo, MM Bui, A Chatzipli, BC Dickson, DC Borcherding, A Feber, A Galor, J Hart, KB Jones, JT Jordan, RH Kim, D Lindsay, C Miller, Y Nishida, P Proszek, J Serrano, View ORCID ProfileRT Sundby, JJ Szymanski, NJ Ullrich, D Viskochil, X Wang, Genomics of MPNST (GeM) Consortium, View ORCID ProfileM Snuderl, PJ Park, AM Flanagan, View ORCID ProfileAC Hirbe, N Pillay, View ORCID ProfileDT Miller
doi: https://doi.org/10.1101/2022.05.03.490481
I Cortes-Ciriano
1European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridge, CB10 1SD, United Kingdom
CD Steele
2Research Department of Pathology, University College London Cancer Institute, Bloomsbury, London, WC1E 6BT, United Kingdom
K Piculell
3Division of Genetics and Genomics, Boston Children’s Hospital, Boston, Massachusetts, 02115, United States of America
A Al-Ibraheemi
4Department of Pathology, Boston Children’s Hospital, Boston, Massachusetts, 02115, United States of America
V Eulo
5Division of Oncology, Department of Internal Medicine, University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States of America
MM Bui
6Department of Pathology, Moffitt Cancer Center & Research Institute, Tampa, Florida, 33612, United States of America
A Chatzipli
7Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, 02115, United States of America
BC Dickson
8Department of Laboratory Medicine and Pathobiology, University of Toronto; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5, Canada
DC Borcherding
9Division of Oncology, Departments of Internal Medicine and Pediatrics, Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, 63110, United States of America
A Feber
10Clinical Genomics Translational Research, Institute of Cancer Research, Royal Marsden NHS Foundation Trust, London, SM2 5NG, United Kingdom
A Galor
11University of Oxford, Wellcome Centre for Human Genetics, Oxford, OX3 7BN, United Kingdom
J Hart
12Department of Pathology, Lifespan Laboratories, Rhode Island Hospital, Providence, Rhode Island, 02903, United States of America
KB Jones
13Departments of Orthopaedics and Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, 84112, United States of America
JT Jordan
14Pappas Center for Neuro-oncology, Massachusetts General Hospital, Boston, Massachusetts, 02114, United States of America
RH Kim
15Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Sinai Health System, Hospital for Sick Children, University of Toronto, Ontario Institute for Cancer Research, Toronto, Ontario, M5G 1Z5, Canada
D Lindsay
16Department of Histopathology, Royal National Orthopaedic Hospital, NHS Trust, Middlesex, HA7 4LP, United Kingdom
C Miller
1European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridge, CB10 1SD, United Kingdom
Y Nishida
17Department of Rehabilitation Medicine, Nagoya University Hospital, Nagoya, Aichi, 466-8550, Japan
P Proszek
10Clinical Genomics Translational Research, Institute of Cancer Research, Royal Marsden NHS Foundation Trust, London, SM2 5NG, United Kingdom
J Serrano
18Department of Pathology, New York University Langone Health, Perlmutter Cancer Center, New York City, New York, 10016, United States of America
RT Sundby
19Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 20892, United States of America
JJ Szymanski
20Division of Cancer Biology, Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, 63108, United States of America
NJ Ullrich
21Department of Neurology, Boston Children’s Hospital, Boston, Massachusetts, 02115 United States of America
D Viskochil
22Division of Medical Genetics, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, 84108, United States of America
X Wang
23GeneHome, Department of Individualized Cancer Management, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, 33612, United States of America
M Snuderl
18Department of Pathology, New York University Langone Health, Perlmutter Cancer Center, New York City, New York, 10016, United States of America
PJ Park
7Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, 02115, United States of America
AM Flanagan
2Research Department of Pathology, University College London Cancer Institute, Bloomsbury, London, WC1E 6BT, United Kingdom
16Department of Histopathology, Royal National Orthopaedic Hospital, NHS Trust, Middlesex, HA7 4LP, United Kingdom
AC Hirbe
9Division of Oncology, Departments of Internal Medicine and Pediatrics, Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, 63110, United States of America
N Pillay
2Research Department of Pathology, University College London Cancer Institute, Bloomsbury, London, WC1E 6BT, United Kingdom
16Department of Histopathology, Royal National Orthopaedic Hospital, NHS Trust, Middlesex, HA7 4LP, United Kingdom
DT Miller
3Division of Genetics and Genomics, Boston Children’s Hospital, Boston, Massachusetts, 02115, United States of America
Article usage
Posted May 11, 2022.
Genomic patterns of malignant peripheral nerve sheath tumour (MPNST) evolution correlate with clinical outcome and are detectable in cell-free DNA
I Cortes-Ciriano, CD Steele, K Piculell, A Al-Ibraheemi, V Eulo, MM Bui, A Chatzipli, BC Dickson, DC Borcherding, A Feber, A Galor, J Hart, KB Jones, JT Jordan, RH Kim, D Lindsay, C Miller, Y Nishida, P Proszek, J Serrano, RT Sundby, JJ Szymanski, NJ Ullrich, D Viskochil, X Wang, Genomics of MPNST (GeM) Consortium, M Snuderl, PJ Park, AM Flanagan, AC Hirbe, N Pillay, DT Miller
bioRxiv 2022.05.03.490481; doi: https://doi.org/10.1101/2022.05.03.490481
Genomic patterns of malignant peripheral nerve sheath tumour (MPNST) evolution correlate with clinical outcome and are detectable in cell-free DNA
I Cortes-Ciriano, CD Steele, K Piculell, A Al-Ibraheemi, V Eulo, MM Bui, A Chatzipli, BC Dickson, DC Borcherding, A Feber, A Galor, J Hart, KB Jones, JT Jordan, RH Kim, D Lindsay, C Miller, Y Nishida, P Proszek, J Serrano, RT Sundby, JJ Szymanski, NJ Ullrich, D Viskochil, X Wang, Genomics of MPNST (GeM) Consortium, M Snuderl, PJ Park, AM Flanagan, AC Hirbe, N Pillay, DT Miller
bioRxiv 2022.05.03.490481; doi: https://doi.org/10.1101/2022.05.03.490481
Subject Area
Subject Areas
- Biochemistry (11752)
- Bioengineering (8752)
- Bioinformatics (29200)
- Biophysics (14974)
- Cancer Biology (12096)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14182)
- Epidemiology (2067)
- Evolutionary Biology (18308)
- Genetics (12245)
- Genomics (16803)
- Immunology (11869)
- Microbiology (28097)
- Molecular Biology (11594)
- Neuroscience (60969)
- Paleontology (451)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2886)
- Systems Biology (7340)
- Zoology (1651)